Results 191 to 200 of about 2,787,448 (332)

A Recombinant Antibody Against ALK2 Promotes Tissue Iron Redistribution and Contributes to Anemia Resolution in a Mouse Model of Anemia of Inflammation

American Journal of Hematology, Volume 100, Issue 5, Page 797-812, May 2025.
ABSTRACT Patients with chronic inflammation are burdened with anemia of inflammation (AI), where inflammatory cytokines inhibit erythropoiesis, impede erythropoietin production, and limit iron availability by inducing the iron regulator hepcidin. High hepcidin hinders iron absorption and recycling, thereby worsening the impaired erythropoiesis by ...
Chia‐Yu Wang, Emiliano Melgar‐Bermudez, Diana Welch, Kevin B. Dagbay, Seemana Bhattacharya, Evan Lema, Tyler Daman, Olivia Sierra, Radina Todorova, Papa Makhtar Drame, Rosa Grenha, Ffolliott M. Fisher, Dena Grayson, Lorena Lerner, Samuel M. Cadena, Jasbir Seehra, Jennifer Lachey   +16 more
wiley   +1 more source

International Consensus (ICON): allergic reactions to vaccines

World Allergy Organization Journal, 2016
Background Routine immunization, one of the most effective public health interventions, has effectively reduced death and morbidity due to a variety of infectious diseases.
Stephen C. Dreskin, Neal A. Halsey, John M. Kelso, Robert A. Wood, Donna S. Hummell, Kathryn M. Edwards, Jean-Christoph Caubet, Renata J.M. Engler, Michael S. Gold, Claude Ponvert, Pascal Demoly, Mario Sanchez-Borges, Antonella Muraro, James T. Li, Menachem Rottem, Lanny J. Rosenwasser   +15 more
doaj  

Fifty years of the american academy of allergy and immunology

, 1993
B ZWEIMAN
openalex   +1 more source

Importance of technology for the future of allergy and immunology [PDF]

, 2004
William T. Shearer
openalex   +1 more source

Ferric Carboxymaltose (FCM)–Associated Hypophosphatemia (HPP): A Systematic Review

American Journal of Hematology, Volume 100, Issue 5, Page 840-846, May 2025.
ABSTRACT Background Since 2015, ferric carboxymaltose (FCM), an intravenous (IV) iron formulation used for treating iron deficiency anemia (IDA), has been associated with an increasing number of reported hypophosphatemia (HPP) cases. Information on HPP clinical manifestations and incidence has not been reviewed.
Joseph Magagnoli, Kevin Knopf, William J. Hrushesky, Kenneth R. Carson, Charles L. Bennett   +4 more
wiley   +1 more source

Committee report of the training program director's committee of the American Academy of Allergy and Immunology: Recommendations of five subcommittees at a retreat held in January 1989

, 1990
William T. Shearer
openalex   +1 more source

Clinical and Molecular Allergy: a new open access journal that addresses rapidly evolving information in the field of allergy and immunology. [PDF]

, 2004
Guha Krishnaswamy, S. David
openalex   +1 more source

Treatment of Bleeding Episodes With Efanesoctocog Alfa in Previously Treated Patients With Severe Hemophilia A in the Phase 3 XTEND‐1 Study

American Journal of Hematology, Volume 100, Issue 5, Page 813-820, May 2025.
ABSTRACT Despite therapeutic advances, people with hemophilia experience bleeds. These may be life‐threatening, result in permanent joint damage, chronic pain, difficulties with mobility/daily activities, and impact quality of life. In the XTEND‐1 study (NCT04161495), once‐weekly efanesoctocog alfa (50 IU/kg) prophylaxis provided highly effective bleed
Angela C. Weyand, Sandrine Meunier, Nobuaki Suzuki, Linda Bystrická, Graham Neill, Lydia Abad‐Franch, Annemieke Willemze, Alberto Tosetto   +7 more
wiley   +1 more source

RISK FACTORS FOR DEVELOPING ATOPIC DISEASES AND MODERN DIAGNOSTICS METHODS

Педиатрическая фармакология, 2010
The article is devoted to the 29th Congress of the European Academy of Allergy and Clinical Immunology (EAACI-2010) held in the June of 2010 in London.
M.A. Snovskaya, O.V. Kozhevnikova, A.K. Gevorkyan, R.М. Torshkhoeva, L.S. Namazova-Baranova   +4 more
doaj  

Some recent developments in the journal of allergy and clinical immunology

, 1992
Burton Zweiman
openalex   +1 more source